NCT00089882View on ClinicalTrials.gov

Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II

CompletedOBSERVATIONAL
Enrollment

360

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Alzheimer Disease
Interventions
PROCEDURE

APOE Genetic susceptibility testing

Trial Locations (4)

10021

Weill Medical College of Cornell University, Memory Disorders Program, New York

20059

Howard University College of Medicine, National Human Genome Center, Washington D.C.

44120

Case Western Reserve University, Memory and Aging Center, Cleveland

02118

Boston University School of Medicine, Alzheimer's Disease Center, Boston

All Listed Sponsors
collaborator

National Human Genome Research Institute (NHGRI)

NIH

lead

National Institute on Aging (NIA)

NIH

NCT00089882 - Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II | Biotech Hunter | Biotech Hunter